Latest Hemoproteins Stories
A team of researchers led by scientists at Weill Cornell Medical College has designed what appears to be a powerful gene therapy strategy that can treat both beta-thalassemia disease and sickle cell anemia.
A recent study shows that the presence of H. pylori bacteria is associated with elevated levels of glycosylated hemoglobin (HbA1c), an important biomarker for blood glucose levels and diabetes.
A University of Michigan Health System laboratory study reveals a key trigger for producing normal red blood cells that could lead to a new treatment for those with sickle cell disease.
Professor Qin Wenbin from BaoTou Medical College first identified the hemoglobin (Hb) A2 phenomenon 30 years ago.
- Withering but not falling off, as a blossom that persists on a twig after flowering.